Progress in clinical application of caffeine in neonates
10.3760/cma.j.issn.1673-4408.2017.02.016
- VernacularTitle:咖啡因在新生儿的临床应用进展
- Author:
Yu SHAO
- Keywords:
Caffeine;
Apnea;
Newborn
- From:
International Journal of Pediatrics
2017;44(2):135-138
- CountryChina
- Language:Chinese
-
Abstract:
Caffeine is a methylxanthine alkaloid compound,which is not only effective,but also safe and needn't monitor the plasma concentration for the prevention and treatment of apnea in preterm infants,compared with theophylline.In recent years,it has been reported that caffeine is beneficial to improve weaning extubation success rate,reduce the incidence of bronchopulmonary dysplasia in preterm infants,reduce the risk of surgical closure of patent ductus arteriosus,and improve the long-term neurological outcome in preterm infants.
